EPISODE · Dec 22, 2025 · 7 MIN
Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
from The Lancet Respiratory Medicine in conversation with · host The Lancet Group
Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment. Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Embed this episode
NOW PLAYING
Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.